Status:

UNKNOWN

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation

Lead Sponsor:

Canisius-Wilhelmina Hospital

Collaborating Sponsors:

Maastricht University Medical Center

Conditions:

Emphysema or COPD

Aneurysm

Eligibility:

All Genders

18+ years

Brief Summary

Background: Elastin is a unique protein providing elasticity, resilience and deformability to dynamic tissues, such as lungs and vasculature. Elastin fibers are characterized by their high affinity fo...

Eligibility Criteria

Inclusion

  • Use of VKAs for at least 3 months
  • Stop VKAs at short time
  • Written informed consent
  • Age ≥18 years
  • Ability to comply with all study requirements

Exclusion

  • Active malignancy or cured malignancy \<12 months prior to enrollment
  • Use of maintenance dose oral corticosteroids
  • Serious mental impairment
  • Life expectation of less than 6 months on the basis of concurrent disease

Key Trial Info

Start Date :

October 31 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2018

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03285100

Start Date

October 31 2017

End Date

October 1 2018

Last Update

January 25 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Canisius Wilhelmina Hospital

Nijmegen, Netherlands, 6532SZ

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation | DecenTrialz